I DON'T MAKE ANY MONEY OFF THIS SITE

If this helps you and you want to make sure it continues, please donate.

Donate
Back to results

FDA Issues Additional Tazverik Blood Cancer Warnings After Market Recall

via AboutLawsuits Published: May 15, 2026

Summary

Federal regulators have concluded that Tazverik blood cancer rates make the lymphoma drug a bigger risk to patients' health than its benefits, urging providers to stop its use immediately.

Read full article β†’